ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA – Get Free Report) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totalling 19,900 ...

Fitbit's lineup offers a range of options, from the Fitbit Luxe to the Versa 4. Here's how to decide which is best for ...

By Seth Millstein for Sentient. Broadcast version by Mark Moran for Iowa News Service reporting for the Sentient-Public News ...

Digital Pathology IndustryThe global digital pathology market is experiencing rapid growth, with an estimated valuation of USD 7,035.8 million in 2023. By 2033, the market is projected to surge to USD ...

XRP could rally to a new all-time high above $4.50 but faces a key resistance hurdle at $2.90.

The Mid Cap Value portfolio was down 5.50% in the fourth quarter, trailing the Russell Midcap® Value Index, which fell 1.75%.

The U.S. Supreme Court unanimously upheld plaintiffs’ ability to divest federal courts of jurisdiction through post-removal amendments to ...

Day One Biopharmaceuticals focuses on pediatric cancer treatments. Read more about the biotech's therapies and its prospects ...

China said it would stop exports of germanium, gallium and antimony to the U.S., citing national security concerns ...

The largest frame in the Aura range is a real showstopper, it's packed with features and makes it easy for multiple users to ...

Every successful business needs two things: a brand and a budget. However developing and protecting your brand without ...